Global Autoimmune Treatment Market Soars to $288.32 Billion by 2028, Driven by a 7.72% CAGR from 2023

DUBLIN, Aug. 24, 2023 /PRNewswire/ -- The "Global Autoimmune Treatment Market (2023-2028) by End Users, Applications, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering.

The Global Autoimmune Treatment Market is estimated to be USD 198.78 Bn in 2023 and is expected to reach USD 288.32 Bn by 2028, growing at a CAGR of 7.72%.

Therapies that modify the immune system are used to reduce or control the body's attack on its own healthy cells. Immunosuppressants, corticosteroids, and biologics are frequently used to treat autoimmune diseases, lowering inflammation and minimizing immune reactions against the body's own tissues.

The autoimmune therapy market is growing rapidly as the prevalence of autoimmune disorders rises and the population ages. Medical research and technology advancements have resulted in the creation of more effective treatments, which has encouraged the adoption of autoimmune therapies in various medical sectors, including rheumatology, dermatology, and gastroenterology, among others.

Autoimmune treatments have grown in popularity due to their proven effectiveness and low cost compared to standard medicines. Patients and healthcare professionals are increasingly choosing these treatments because they deliver superior long-term outcomes and lower treatment costs, making them a preferred choice in controlling chronic autoimmune disorders.

The autoimmune treatment industry provides an opportunity for enhanced sensor integration in medical equipment and treatment techniques. These sensors can monitor patients' status in real-time, providing crucial data for personalized and accurate treatment approaches. Innovative sensor technology can improve treatment efficacy and patient outcomes, supporting innovation in the management of autoimmune therapies.

The autoimmune treatment industry can profit from the fast improvements and acceptance of robotics in process automation. Robotic technologies can potentially improve many elements of autoimmune treatment, including drug manufacturing, laboratory processing, and surgical operations. Implementing robotics in the sector may enhance productivity, lower costs, and better patient care, offering promising market opportunities.

However, the absence of uniform norms and regulations to produce autoimmune therapy products can lead to differences in product quality, safety concerns, and interoperability issues, providing challenges for manufacturers, healthcare practitioners, and patient care.

Certain sensors utilized in autoimmune treatment may have shorter response times and less precision when compared to optical sensors. This has the potential to have an impact on real-time monitoring and data collection for effective medication management.

Market Segmentations

The Global Autoimmune Treatment Market is segmented based on End Users, Applications, and Geography.

• By Product, the market is classified into Diagnostic Equipment and Drugs.

Drugs hold a larger market share. Since autoimmune disorders are chronic, the demand for pharmaceutical treatments is larger, putting a greater emphasis on drug research and therapy choices over diagnostic tools.

• By Application, the market is classified into Localized Autoimmune Diseases, Systemic Autoimmune Diseases.

Systemic autoimmune diseases hold a significant market share. Systemic conditions such as rheumatoid arthritis, lupus, and psoriasis affect numerous organs and are more common, increasing demand for therapies, research, and therapeutic developments in this area.

• By Geography, the market is classified into the Americas, Europe, Middle-East & Africa, and Asia-Pacific.

The Americas hold a larger market share. This is mainly due to the region's greater incidence of autoimmune disorders, increased awareness of potential therapies, improved healthcare infrastructure, and major R&D investments.

Recent Developments

EUROIMMUN launches new automated IIFT system - June 2023
Pfizer and Roivant launch autoimmune specialist Priovant - June 2022

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are Amgen Inc., AstraZeneca PLC, Biocryst Pharmaceuticals Inc, Novartis AG, etc.

Countries Studied

• America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
• Europe (Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxemburg, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
• Middle-East and Africa (Egypt, Israel, Qatar, Nigeria, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
• Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Autoimmune Treatment Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Autoimmune Treatment Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, The analyst has devised suitable strategies for market growth.

Why buy this report?

• The report offers a comprehensive evaluation of the Global Autoimmune Treatment Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
• The research report also provides a detailed market size analysis and projections in volume and value terms. The projections are calculated using verified research methodologies.
• Excel data sheet for the market size will also be provided with the report.
• The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
• The report includes an in-depth market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.
• The report includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
• The report includes Self-Assessment Form, which helps customers evaluate their position in the market compared to their competitors
• The report offers customized research - tailored uniquely to our customers with a quick turnaround time. We offer a 15% customization option at no extra charge to all our clients for any of our syndicated reports.

Report Highlights:

• A complete analysis of the market, including the parent industry
• Important market dynamics and trends
• Impact Analysis - a comprehensive assessment to confront risk and make strategic & operational decisions to counter the changes in the market environment.
• Market segmentation
• Competitive Analysis: Comparative analysis of competitor
• Historical, current, and projected size of the market based on value and volume
• Market size of the US states
• Market shares and strategies of key players
• Recommendations to companies for strengthening their foothold in the market

Key Topics Covered:

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Analyst Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook

4 Market Dynamics
4.1 Impact Analysis
4.2 Drivers
4.2.1 Growing Application in Medical Industry
4.2.2 Increase in demand due to its Reliability, and Cost-Effectiveness
4.3 Restraints
4.3.1 Lack of Manufacturing Standards
4.4 Opportunities
4.4.1 Development of Advanced Sensors
4.4.2 Rapid Development and Adoption of Robotics in Process Automation
4.5 Challenges
4.5.1 Reduced Reaction Speed and Precision than Optical Sensors

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 Impact of COVID-19
5.5 Ansoff Matrix Analysis

6 Global Autoimmune Treatment Market, By Products
6.1 Introduction
6.2 Diagnostic Equipment
6.3 Drugs

7 Global Autoimmune Treatment Market, By Application
7.1 Introduction
7.2 Localized Autoimmune Diseases
7.3 Systemic Autoimmune Diseases

8 Americas' Autoimmune Treatment Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas

9 Europe's Autoimmune Treatment Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Ireland
9.9 Italy
9.10 Luxembourg
9.11 Netherlands
9.12 Norway
9.13 Poland
9.14 Russia
9.15 Spain
9.16 Sweden
9.17 Switzerland
9.18 United Kingdom
9.19 Rest of Europe

10 Middle East and Africa's Autoimmune Treatment Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Nigeria
10.6 Saudi Arabia
10.7 South Africa
10.8 United Arab Emirates
10.9 Rest of MEA

11 APAC's Autoimmune Treatment Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific

12 Competitive Landscape
12.1 Analyst Competitive Quadrant
12.2 Market Share Analysis

13 Company Profiles
13.1 Abbott Laboratories
13.1.1 Company Overview
13.1.2 Company Snapshot
13.1.3 Product Overview
13.1.4 Business Overview
13.1.5 SWOT Analysis
13.1.6 Recent Developments
13.2 AbbVie Inc.
13.2.1 Company Overview
13.2.2 Company Snapshot
13.2.3 Product Overview
13.2.4 Business Overview
13.2.5 SWOT Analysis
13.2.6 Recent Developments
13.3 Active Biotech
13.3.1 Company Overview
13.3.2 Company Snapshot
13.3.3 Product Overview
13.3.4 Business Overview
13.3.5 SWOT Analysis
13.3.6 Recent Developments
13.4 Amgen Inc.
13.4.1 Company Overview
13.4.2 Company Snapshot
13.4.3 Product Overview
13.4.4 Business Overview
13.4.5 SWOT Analysis
13.4.6 Recent Developments
13.5 Astellas Pharma Inc
13.5.1 Company Overview
13.5.2 Company Snapshot
13.5.3 Product Overview
13.5.4 Business Overview
13.5.5 SWOT Analysis
13.5.6 Recent Developments
13.6 AstraZeneca PLC
13.6.1 Company Overview
13.6.2 Company Snapshot
13.6.3 Product Overview
13.6.4 Business Overview
13.6.5 SWOT Analysis
13.6.6 Recent Developments
13.7 Autoimmune Inc
13.7.1 Company Overview
13.7.2 Company Snapshot
13.7.3 Product Overview
13.7.4 Business Overview
13.7.5 SWOT Analysis
13.7.6 Recent Developments
13.8 Bayer AG
13.8.1 Company Overview
13.8.2 Company Snapshot
13.8.3 Product Overview
13.8.4 Business Overview
13.8.5 SWOT Analysis
13.8.6 Recent Developments
13.9 Biocryst Pharmaceuticals Inc.
13.9.1 Company Overview
13.9.2 Company Snapshot
13.9.3 Product Overview
13.9.4 Business Overview
13.9.5 SWOT Analysis
13.9.6 Recent Developments
13.10 Biogen Inc
13.10.1 Company Overview
13.10.2 Company Snapshot
13.10.3 Product Overview
13.10.4 Business Overview
13.10.5 SWOT Analysis
13.10.6 Recent Developments
13.11 Biomerieux SA
13.11.1 Company Overview
13.11.2 Company Snapshot
13.11.3 Product Overview
13.11.4 Business Overview
13.11.5 SWOT Analysis
13.11.6 Recent Developments
13.12 Bio-rad Laboratories
13.12.1 Company Overview
13.12.2 Company Snapshot
13.12.3 Product Overview
13.12.4 Business Overview
13.12.5 SWOT Analysis
13.12.6 Recent Developments
13.13 Boehringer Ingelheim International GmbH
13.13.1 Company Overview
13.13.2 Company Snapshot
13.13.3 Product Overview
13.13.4 Business Overview
13.13.5 SWOT Analysis
13.13.6 Recent Developments
13.14 Bristol-Myers Squibb
13.14.1 Company Overview
13.14.2 Company Snapshot
13.14.3 Product Overview
13.14.4 Business Overview
13.14.5 SWOT Analysis
13.14.6 Recent Developments
13.15 Johnson & Johnson Services, Inc
13.15.1 Company Overview
13.15.2 Company Snapshot
13.15.3 Product Overview
13.15.4 Business Overview
13.15.5 SWOT Analysis
13.15.6 Recent Developments
13.16 Lupin Limited
13.16.1 Company Overview
13.16.2 Company Snapshot
13.16.3 Product Overview
13.16.4 Business Overview
13.16.5 SWOT Analysis
13.16.6 Recent Developments
13.17 Myriad Genetics
13.17.1 Company Overview
13.17.2 Company Snapshot
13.17.3 Product Overview
13.17.4 Business Overview
13.17.5 SWOT Analysis
13.17.6 Recent Developments
13.18 Novartis AG
13.18.1 Company Overview
13.18.2 Company Snapshot
13.18.3 Product Overview
13.18.4 Business Overview
13.18.5 SWOT Analysis
13.18.6 Recent Developments
13.19 Pfizer Inc.
13.19.1 Company Overview
13.19.2 Company Snapshot
13.19.3 Product Overview
13.19.4 Business Overview
13.19.5 SWOT Analysis
13.19.6 Recent Developments
13.20 Werfen Group
13.20.1 Company Overview
13.20.2 Company Snapshot
13.20.3 Product Overview
13.20.4 Business Overview
13.20.5 SWOT Analysis
13.20.6 Recent Developments

14 Appendix
14.1 Self-Assessment Form

Companies Mentioned

• Abbott Laboratories
• AbbVie Inc.
• Active Biotech
• Amgen Inc.
• Astellas Pharma Inc
• AstraZeneca PLC
• Autoimmune Inc
• Bayer AG
• Biocryst Pharmaceuticals Inc.
• Biogen Inc
• Biomerieux SA
• Bio-rad Laboratories
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb
• Johnson & Johnson Services, Inc
• Lupin Limited
• Myriad Genetics
• Novartis AG
• Pfizer Inc.
• Werfen Group

For more information about this report visit https://www.researchandmarkets.com/r/s9bcln

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]  
 
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
 
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets